What did @femalehealthdoc actually say?
A doctor who is already on hormone replacement therapy shared her own blood test results at 10 to 12 weeks after adding testosterone. She found her total testosterone came in at 3 nmol/L, slightly above the female reference range of under 2.6 nmol/L. Her free androgen index landed at 3.26%, above her preferred range of 2 to 3%. Her response? She plans to reduce her dose, either to every other day or once a week, then retest in 12 weeks. If levels stay high, she says she will stop testosterone altogether.
This is a self-experiment, not a clinical trial. She is narrating her own management decision in real time, which is both the video's strength and its limitation. She is not telling you what to do. That nuance matters when millions of people watch these clips looking for instructions.
Does the science back this up?
Mostly, yes. The reference ranges she cites are consistent with established clinical guidelines, and the step-down approach she describes is a recognized harm-reduction strategy. But the evidence base for female testosterone therapy is thinner than most TikTok viewers realize.
The British Menopause Society and the Endocrine Society both acknowledge testosterone use in women primarily for hypoactive sexual desire disorder, but neither has endorsed broad hormone optimization protocols. A 2019 global consensus statement published in the Journal of Clinical Endocrinology and Metabolism (Islam et al., 2019) set a physiologic serum testosterone target for women at no higher than the upper limit of the normal female range. The creator's result at 3 nmol/L is modestly above that ceiling, which is why she is self-correcting.
The free androgen index, which estimates how much testosterone is biologically active rather than protein-bound, is a reasonable secondary marker, though some endocrinologists prefer free testosterone measured by equilibrium dialysis for accuracy. Her use of FAI as a secondary check is clinically sensible, even if imperfect.
What did they get wrong (or right)?
She got the clinical logic right. Seeing above-range results and reducing dose rather than continuing is exactly what responsible prescribing looks like. She also flagged the correct decision threshold: if levels remain elevated consistently, stopping the therapy is appropriate. That is a genuinely responsible message.
What she did not address, and this matters for viewers, is that symptoms matter as much as numbers. The Endocrine Society's 2014 clinical practice guideline on androgen therapy in women (Wierman et al., 2014, Journal of Clinical Endocrinology and Metabolism) emphasizes that serum testosterone alone is a poor predictor of clinical response because individual sensitivity to androgens varies substantially. A woman with a testosterone level of 2.4 nmol/L might have more androgenic side effects than one at 3.1 nmol/L, depending on androgen receptor sensitivity and SHBG levels.
She also did not mention potential side effects of sustained supraphysiologic levels, including acne, hair thinning, clitoral sensitivity changes, and voice changes. Those are not scare tactics. They are documented in the literature, and viewers deserve to hear them.
What should you actually know?
Female testosterone therapy is real, used clinically, and has a legitimate evidence base for specific indications. But it is not a wellness supplement you dial up or down based on a TikTok video, even one made by a doctor managing her own labs.
A few things worth knowing before you consider this for yourself:
- The FDA has not approved any testosterone product specifically for women in the United States. Women using testosterone are doing so off-label, typically with compounded preparations or male-formulated products at reduced doses.
- Reference ranges for female testosterone vary significantly between labs and assay methods, which means a result of 3 nmol/L at one lab is not directly comparable to 3 nmol/L at another.
- The Islam et al. 2019 consensus paper specifically warns against using testosterone for general fatigue, mood, or cognitive symptoms in the absence of a diagnosed deficiency, because the evidence does not support those uses.
- Self-managing any hormone therapy without clinical oversight is risky. This creator is a doctor. She knows how to read her own labs. Most viewers are not in that position.
The video is more responsible than most hormone content on TikTok. But watching a doctor adjust her own dose is not the same as getting personalized medical advice, and that line gets blurry fast in a 60-second clip.